Methods and Technologies Branch (MTB)

The vision of the Methods and Technologies Branch (MTB) is to advance population science through innovative cancer epidemiology utilizing state-of-the-art, emerging and advanced methods and technologies.

MTB's mission is to empower cancer epidemiologists with innovative and advanced methods/technologies to conduct cancer epidemiology. The Branch supports planning, developing, directing, validating, and evaluating:

  • Methods/technologies for conducting cancer epidemiology, particularly the methods/technologies suitable for understanding cancer etiology, identifying at risk population, assessing cancer incidence, prevalence, survival and mortality in populations;
  • Emerging and advanced methods/technologies which allow analysis of both endogenous (e.g., genomic, epigenomic, proteomic and metabolomic) and exogenous factors (e.g., chemical, drug, tobacco, and microbes), and the interactions between the host and the environment that increase or decrease cancer risk/survival;
  • Robust methods/technologies for screening molecular markers (e.g., pre-neoplastic and neoplastic markers; inflammation markers; chemical/drug induced molecular changes; [i.e., the molecular markers of exposure]), which will be suitable for risk stratification in clinical/molecular epidemiology;Advanced methods/technologies for integrating epidemiological, clinical, molecular and environmental data to assess risk/susceptibility/survival;
  • Methods/technologies for assessing quality, integrity, and utility of fresh or archived biospecimens, both liquid and tissue specimens to conduct retrospective and prospective epidemiological studies; and
  • Robust prediction/prognostic models for cancer risk/outcomes.

MTB also disseminates findings from the research supported by the Branch to the public at-large, epidemiologists, and public health professionals involved in cancer prevention, care and control.


MTB Staff

Branch Name / Title / Contact Info Interest Areas
MTB

Verma, Mukesh, Ph.D.
Branch Chief

Phone: (240) 276-6889
Email: vermam@mail.nih.gov

  • Biomarkers
  • Epigenetics
  • Epidemiology Technologies
  • Proteomics
  • MicroRNA
  • Methylation
  • Mitochondria
  • Nanotechnology
  • Risk Assessment
  • Susceptibility Factors
  • Systems Genetics
  • Metabolomics
MTB

Cook, Sherri
Program Support Assistant

Phone: (240) 276-6937
Email: cooksh@od.nih.gov

  • Not Available
MTB

Divi, Rao L., Ph.D.
Program Director

Phone: (240) 276-6913
Email: divir@mail.nih.gov

  • Methods for Cancer Epidemiology
  • DNA Damage
  • Genomic Rearrangements
  • Chromosomal Translocations
  • Retrotransposons
  • Preclinical Markers
  • MicroRNA
  • Carcinogenesis
  • Transcriptomics
  • Functional Genomics
  • Molecular Markers
  • Methods for Risk Assessment
  • Toxicity and Carcinogenicity
  • High-Throughput Screening
  • Bioinformatics
  • Exposome
  • Exosomes
  • Oncosomes
MTB

Hebert, Elizabeth
Cancer Research Training Award Fellow

Phone: (240) 276-5946
Email: hebertef@mail.nih.gov

  • Neuroscience
  • Neurochemistry
  • Genetics
MTB

Overton, Adrienne, M.P.A.
Program Analyst

Phone: (240) 276-6682
Email: overtona@mail.nih.gov

  • Infectious diseases
  • Non-communicable diseases
  • Health disparities/underserved populations
  • Health policy
MTB

Starks, Vaurice L.
Program Director

Phone: (240) 276-6968
Email: starksv@mail.nih.gov

  • Infectious disease epidemiology
  • Focusing on HIV and HPV

Return to Top